Skip to content
Wednesday, November 11, 2026
PowerCore Global

Zimbabwe Declines ‘One-Sided’ US Health Aid Deal Because of Data Apprehensions

Medical aid illustration
The proposed US funding would have supported initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has turned down a major US health deal worth 367 million US dollars (272 million pounds) spanning five years due to Washington's demand for confidential information.

This move became public after a official document from December was disclosed, which showed President Emmerson Mnangagwa deemed the agreement was "lopsided".

An official spokesman later explained that the US was requesting genetic material for research and commercial purposes while refused to share the resulting advantages from any future medical innovations.

"We are forced to start the difficult and regrettable process of ending our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the US had provided over $1.9bn in health funding to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has urged more talks to reach a agreement agreeable to all parties so the nation's critical HIV treatment initiative can continue.

Broader Implications

This development comes after a similar case in Kenya, where a high court suspended a similar deal with the US following concerns were raised about the security of Kenyans' medical information.

Since returning to office recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.

The agency had overseen aid for the US government, but Trump stated its spending was "inefficient" and his administration was seeking direct bilateral agreements to boost transparency and accountability.

According to statements, 16 African countries have to date signed these new agreements, constituting over $18.3bn in new funding.

Details of the Declined Deal

The funds for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this collaboration could have provided extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported initiatives," Tremont said.

However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".

"Zimbabwe was being asked to share its biological resources and data over an extended period, with no equivalent guarantee of access to any medical innovations – such as new medicines or tests – that might be developed from that provided information," Mangwana explained.

"In essence, our country would supply the raw materials for scientific discovery without any certainty that the end products would be accessible to our population if a new disease outbreak emerge."

Sovereignty and Global Health

Mangwana further said that the US's withdrawal from the global health body and its pursuit of one-on-one deals were disrupting systems already set up via the global organization.

Mangwana gave as an example its Pandemic Benefit-Sharing scheme designed to manage future global health emergencies.

"This system is intended to guarantee that when a country provides its data, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised solely by those with the capability to develop them."

Zimbabwe's reservations over the US deal "are not meant as hostility towards the US," Mangwana stressed.

"We are open to ongoing discussions with our American counterparts on how subsequent collaboration might be arranged in a manner that respects the independence and interests of both nations."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the official position, but urged that negotiations must proceed considering much of the country's HIV programmes were funded by foreign aid.

"Where technical issues exist, including those involving data governance or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," the group said.

The halted deal underscores the complex challenges between accepting vital international aid and protecting local interests in an ever more interconnected world.

BC
Written by

Brian Camacho

Elara Vance is a renewable energy consultant with over a decade of experience in sustainable infrastructure projects across Europe.

PowerCore Global

Type to search articles.